Last 27 quarters of trend data · Healthcare · Medical - Healthcare Information Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.08 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.85 | 0.73 | 0.40 | 0.36 | 0.44 | 0.50 | 0.46 | 0.39 | 0.59 | 0.38 | 1.00 | 1.52 | 1.35 | 2.38 | 2.58 | 2.49 | 3.60 | 4.58 | 4.39 | 5.52 | 9.42 |
| — | +47.4% | -14.0% | -7.4% | -24.6% | +29.4% | -53.6% | -74.1% | -56.5% | -83.8% | -61.4% | -39.0% | -62.5% | -48.0% | -41.2% | -55.0% | -61.8% | -64.9% | -76.1% | -37.1% | +16.1% | |
| P/B Ratio | 0.80 | 0.65 | 0.36 | 0.32 | 0.37 | 0.48 | 0.40 | 0.35 | 0.41 | 0.26 | 0.56 | 0.89 | 0.64 | 0.92 | 0.93 | 0.73 | 0.90 | 1.02 | 0.93 | 1.27 | 1.81 |
| — | +36.0% | -10.0% | -8.0% | -9.0% | +87.4% | -27.9% | -60.5% | -36.3% | -72.3% | -39.4% | +22.9% | -28.6% | -9.2% | -0.9% | -42.9% | -50.1% | -61.3% | -73.2% | -25.2% | +15.4% | |
| P/FCF | — | 2.83 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.3% | 53.0% | 37.2% | 51.2% | 52.4% | 56.1% | 52.8% | 48.4% | 37.2% | 37.4% | 30.9% | 33.7% | 34.7% | 38.8% | 39.5% | 42.4% | 40.0% | 43.4% | 42.8% | 39.9% | 43.5% |
| — | -5.6% | -29.5% | +5.8% | +41.0% | +49.8% | +71.0% | +43.6% | +7.2% | -3.5% | -21.8% | -20.4% | -13.4% | -10.8% | -7.7% | +6.1% | -7.9% | -0.7% | +12.5% | +6.7% | +33.0% | |
| Operating Margin | -42.2% | -18.4% | -23.6% | -45.5% | -52.1% | -28.7% | -45.5% | -60.2% | -77.6% | -83.4% | -126.1% | -80.6% | -231.5% | -151.3% | -620.8% | -81.8% | -102.8% | -107.6% | -109.7% | -65.2% | -89.1% |
| — | +36.1% | +48.2% | +24.5% | +32.8% | +65.5% | +63.9% | +25.3% | +66.5% | +44.9% | +79.7% | +1.5% | -125.3% | -40.7% | -465.8% | -25.5% | -15.3% | -72.6% | -63.2% | +20.5% | +13.3% | |
| Net Margin | -38.4% | -19.1% | -19.8% | -45.1% | -57.5% | -27.8% | -28.0% | -60.1% | -71.2% | -79.5% | -121.1% | -68.7% | -220.3% | -148.1% | -621.4% | -77.2% | -101.3% | -107.2% | -109.0% | -65.7% | -82.8% |
| — | +31.3% | +29.1% | +25.0% | +19.2% | +65.1% | +76.9% | +12.6% | +67.7% | +46.3% | +80.5% | +10.9% | -117.5% | -38.2% | -469.9% | -17.5% | -22.4% | -70.5% | -60.3% | +21.1% | +17.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -33.9% | -4.2% | -4.5% | -9.7% | -11.5% | -6.6% | -6.0% | -12.8% | -11.9% | -12.5% | -16.0% | -9.7% | -23.5% | -13.6% | -44.2% | -5.6% | -6.2% | -5.8% | -5.7% | -3.7% | -4.1% |
| — | +36.2% | +25.8% | +24.4% | +3.5% | +47.3% | +62.3% | -31.7% | +49.1% | +8.5% | +63.9% | -73.9% | -279.1% | -133.4% | -679.9% | -49.6% | -49.6% | -85.6% | -78.1% | +5.6% | +41.7% | |
| ROA | -25.2% | -3.0% | -3.4% | -7.3% | -8.7% | -4.9% | -4.4% | -9.3% | -8.8% | -9.5% | -12.7% | -7.9% | -19.4% | -11.4% | -38.5% | -5.0% | -5.5% | -5.2% | -5.0% | -3.3% | -3.7% |
| — | +37.6% | +23.4% | +21.4% | +1.3% | +48.4% | +65.5% | -17.0% | +54.7% | +17.1% | +67.1% | -58.9% | -250.0% | -119.3% | -670.9% | -53.1% | -49.4% | -79.5% | -71.8% | +9.5% | +40.9% | |
| ROIC | -95.1% | -13.5% | -14.4% | -26.6% | -28.6% | -17.7% | -24.4% | -30.4% | -31.5% | -33.2% | -45.8% | -25.7% | -30.4% | -12.8% | -50.7% | -7.2% | -6.2% | -5.3% | -6.7% | -6.7% | -11.1% |
| — | +23.8% | +41.0% | +12.7% | +9.2% | +46.6% | +46.7% | -18.6% | -3.8% | -160.1% | +9.6% | -255.9% | -386.2% | -141.3% | -657.4% | -7.1% | +43.9% | +48.6% | +26.6% | +40.0% | +29.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| — | -41.4% | -30.8% | -29.6% | -21.4% | -17.9% | -7.3% | +5.7% | +8.2% | +31.6% | +32.6% | +79.2% | +67.7% | +45.6% | +43.2% | +4.0% | +2.7% | +287.4% | +179.1% | +114.5% | +93.0% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.37 | 2.90 | 3.09 | 3.37 | 3.14 | 3.29 | 2.92 | 2.85 | 2.92 | 3.21 | 3.82 | 4.79 | 4.95 | 4.86 | 5.09 | 5.49 | 6.25 | 6.08 | 5.85 | 5.84 | 6.72 |
| — | -12.0% | +5.9% | +18.3% | +7.3% | +2.7% | -23.6% | -40.6% | -41.0% | -34.0% | -24.9% | -12.8% | -20.8% | -20.1% | -13.0% | -5.9% | -7.0% | -46.4% | -45.8% | -36.5% | -37.3% | |
| Quick Ratio | 3.35 | 2.89 | 3.08 | 3.35 | 3.11 | 3.27 | 2.89 | 2.82 | 2.88 | 3.16 | 3.76 | 4.72 | 4.87 | 4.78 | 5.02 | 5.42 | 6.18 | 6.01 | 5.79 | 5.79 | 6.65 |
| — | -11.6% | +6.3% | +18.8% | +8.1% | +3.5% | -23.0% | -40.2% | -40.9% | -33.9% | -25.1% | -12.8% | -21.1% | -20.5% | -13.3% | -6.4% | -7.2% | -46.6% | -45.9% | -36.6% | -37.6% | |
| Interest Coverage | — | -16.49 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -145.16 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 27 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMWL stock.
American Well Corporation's current P/E is -2.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
American Well Corporation's current operating margin is -42.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking American Well Corporation's business trajectory between earnings reports.